NEBIUS
NBIS
237.15
-12.72
-5.09%
NEBIUS
US · NBIS
#377 by market cap
Listed 1970
237.15
-12.72
-5.09%
Live - 5344 symbols - heartbeat 59s ago
· 2026-10-08 07:00
Pre-market
231.00
-2.59%
After-hours
238.60
+0.61%
Overnight
233.48
-1.55%
- Market cap
- 64.47B
- P/E (TTM)i
- 329.38
- P/Bi
- 6.24
- EPSi
- 0.33
- Div yieldi
- 0.00%
- 52W posi
- 72%
Reader sentiment
Are you bullish or bearish on NBIS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.50, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +479.02% YoY
Margins
- Gross margin
- 68.63%
- Operating margin
- -115.46%
- Net margin
- 15.57%
Key ratios & quality
- Enterprise valuei
- 65.00B
- Altman Z-Scorei
- 5.50
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.84B | 2.83B | 2.93B | 4.78B | 13.50M | 9.80M | 91.50M | 529.80M |
| Gross profit | 1.32B | 1.93B | 1.78B | 2.44B | -14.90M | -9.80M | 47.80M | 363.60M |
| Selling & admin expenses | 521.00M | 811.26M | 845.55M | 1.65B | 57.30M | 159.50M | 255.50M | 380.10M |
| Research & development | 324.91M | 471.14M | 488.40M | 649.86M | 58.30M | 87.10M | 114.80M | 177.30M |
| Operating profit | 299.92M | 408.44M | 210.62M | -178.04M | -158.00M | -285.70M | -399.60M | -611.70M |
| Pretax profit | 754.89M | 366.49M | 491.14M | -96.86M | -178.90M | -297.00M | -353.00M | 13.80M |
| Tax | 118.01M | 188.01M | 177.31M | 99.64M | 1.10M | 2.00M | -1.00M | 4.00M |
| Net profit | 636.87M | 178.48M | 313.82M | -196.50M | 870.70M | 265.90M | -641.40M | 82.50M |
| Basic EPS | 2 | 1 | 1 | -1 | 2 | 1 | -2 | 0 |
| Diluted EPS | 1.97 | 0.61 | 0.94 | -0.54 | 1.59 | 0.65 | -2.28 | 0.33 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 50.90M | 105.10M | 146.10M | 227.70M | 399.00M | 582.30M |
| Gross profit | 26.20M | 75.00M | 103.20M | 159.20M | 295.20M | 448.70M |
| Selling & admin expenses | 60.90M | 68.20M | 89.50M | 161.50M | 143.80M | 173.90M |
| Research & development | 36.50M | 42.80M | 44.90M | 53.10M | 67.40M | 191.00M |
| Operating profit | -120.30M | -111.20M | -130.20M | -250.00M | -128.00M | -175.90M |
| Pretax profit | -103.40M | 503.30M | -119.90M | -266.20M | 615.40M | -176.70M |
| Tax | 900.00K | 800.00K | -300.00K | 2.60M | -5.80M | 13.70M |
| Net profit | -113.50M | 584.40M | -119.60M | -268.80M | 621.20M | -190.40M |
| Basic EPS | 0 | 2 | -1 | -1 | 2 | -1 |
| Diluted EPS | -0.48 | 2.38 | -0.50 | -0.99 | 2.11 | -0.68 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.32B | 1.94B | 3.90B | 2.68B | 3.22B | 3.45B | 2.53B | 4.71B |
| Cash & ST investments | 990.00M | 1.42B | 3.20B | 1.44B | 1.13B | 121.20M | 2.43B | 3.68B |
| Inventory | 3.81M | 13.03M | 64.65M | 128.56M | 378.79M | 240.38M | -- | -- |
| Total assets | 3.73B | 4.70B | 6.93B | 6.91B | 8.28B | 8.76B | 3.55B | 12.43B |
| Total current liabilities | 428.17M | 750.69M | 844.73M | 1.49B | 2.52B | 3.87B | 264.00M | 1.53B |
| Short-term debt | 93.77M | 178.48M | 120.17M | 200.24M | 470.56M | 16.50M | 19.20M | 109.40M |
| Long-term debt | -- | -- | 1.12B | 1.15B | 401.14M | 558.56M | -- | 4.10B |
| Total liabilities | 639,721,870.07 | 995,075,833.58 | 2,251,334,457.63 | 3,252,876,914.18 | 3,738,805,369.13 | 5,461,200,000.00 | 294,900,000.00 | 7,836,600,000.00 |
| Total equity | 3.09B | 3.70B | 4.68B | 3.66B | 4.54B | 3.29B | 3.25B | 4.59B |
| Retained earnings | 1.60B | 1.97B | 1.96B | 1.76B | 2.33B | 3.86B | 3.22B | 3.30B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.68B | 2.03B | 5.22B | 4.71B | 11.24B | 9.62B |
| Cash & ST investments | 1.45B | 1.68B | 4.79B | 3.68B | 9.30B | 8.04B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 3.44B | 5.10B | 10.10B | 12.43B | 22.30B | 27.96B |
| Total current liabilities | 93.50M | 138.10M | 794.60M | 1.53B | 1.35B | 2.39B |
| Short-term debt | 6.20M | 41.60M | 72.80M | 109.40M | 18.40M | 161.60M |
| Long-term debt | -- | 978.20M | 4.09B | 4.10B | 8.43B | 8.50B |
| Total liabilities | 275,200,000.00 | 1,321,100,000.00 | 5,291,400,000.00 | 7,836,600,000.00 | 15,061,400,000.00 | 17,621,000,000.00 |
| Total equity | 3.16B | 3.78B | 4.81B | 4.59B | 7.24B | 10.34B |
| Retained earnings | 3.10B | 3.69B | 3.57B | 3.30B | 3.92B | 3.73B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 405.97M | 715.83M | 438.20M | 124.62M | 697.00M | 829.80M | 245.60M | 384.80M |
| Depreciation & amortization | 255.95M | 405.49M | 407.81M | 559.47M | 29.50M | 36.40M | 85.80M | 468.50M |
| Free cash flow | -1.60M | 384.47M | 108.23M | -473.75M | 682.40M | 746.90M | -561.90M | -3.68B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -145.12M | -22.94M | 839.80M | -93.41M | 0 | 0 | 700.00M | 1.15B |
| Ending cash balance | 991.27M | 910.59M | 1.78B | 1.06B | 1.20B | 114.10M | 2.44B | 3.72B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -197.50M | -171.60M | -80.40M | 834.30M | 2.26B | 2.25B |
| Depreciation & amortization | 56.10M | 84.70M | 111.80M | 215.90M | 241.80M | 294.30M |
| Free cash flow | -741.40M | -682.20M | -1.04B | -1.22B | -214.90M | -3.41B |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 0 | 1.15B | 0 | -- | 2.85B |
| Ending cash balance | 1.52B | 1.75B | 4.92B | 3.72B | 9.63B | 9.10B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 34.01 | 7.21 | 9.11 | -5.02 | 13.75 | 5.91 | -19.43 | 2.10 |
| ROA %i | 23.85 | 5.06 | 5.90 | -2.84 | 6.97 | 2.62 | -10.32 | 1.03 |
| ROIC %i | 32.27 | 4.82 | 6.96 | -3.70 | 9.35 | 4.99 | -15.65 | 1.61 |
| 5-year avg ROE %i | 18.73 | 15.10 | 14.18 | 11.16 | 12.67 | 7.35 | 1.99 | 0.65 |
| EBIT margin %i | 43.40 | 13.07 | 18.13 | -0.99 | 14.14 | 6.75 | -375.06 | 14.21 |
| FCF / sales %i | -- | 13.59 | 3.69 | -- | -- | -- | -- | -- |
| Current ratioi | 3.09 | 2.58 | 4.62 | 1.80 | 1.28 | 0.89 | 9.60 | 3.08 |
| Quick ratioi | 3.00 | 2.45 | 4.40 | 1.57 | 1.01 | 0.03 | 9.38 | 2.97 |
| Debt / assetsi | 7.36 | 7.52 | 21.03 | 27.31 | 16.82 | 0.30 | 1.39 | 40.01 |
| LT debt / equityi | 7.02 | 5.56 | 30.63 | 48.74 | 21.71 | 0.29 | 0.93 | 105.87 |
| Interest coveragei | 58.63 | 309.85 | 16.68 | -0.95 | 21.72 | 4.97 | -- | 1.22 |
| Revenue CAGR (3Y) %i | 31.18 | 31.65 | 21.63 | 37.51 | -83.16 | -85.05 | -73.24 | 239.83 |
| Net income CAGR (3Y) %i | 71.26 | 22.63 | 27.69 | -- | 53.86 | -10.10 | -- | -51.99 |
| FCF CAGR (3Y) %i | -- | 14.55 | -18.15 | -- | 21.08 | 90.39 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -13.50 | 6.01 | 5.68 | 2.10 | 15.71 | 0.60 |
| ROA %i | -7.26 | 5.12 | 3.33 | 1.03 | 6.35 | 0.26 |
| ROIC %i | -14.70 | 3.88 | 2.91 | 1.61 | 8.66 | 1.48 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -301.92 | 59.93 | 24.44 | 14.21 | 97.71 | 21.56 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 18.00 | 14.70 | 6.57 | 3.08 | 8.33 | 4.03 |
| Quick ratioi | 16.64 | 13.72 | 6.33 | 2.97 | 8.02 | 3.60 |
| Debt / assetsi | 5.46 | 24.02 | 45.23 | 40.01 | 42.58 | 36.38 |
| LT debt / equityi | 5.74 | 31.33 | 93.46 | 105.87 | 130.89 | 96.81 |
| Interest coveragei | -- | -- | -- | 1.22 | 6.85 | 1.22 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Nebius artificial intelligence (AI) cloud is the largest reported line at 98.73% of revenue, across 4 reported segments.
- The next-largest line, Toloka, is a distant second at 1.72% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Nebius artificial intelligence (AI) cloud98.73%
Toloka1.72%
Avride0.17%
Quote time 2026-10-08 07:00:17 · For reference only, not investment advice and not tailored to your situation.